id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-352256-qxdakdk0	Yousefi, Bahman	A global treatments for coronaviruses including COVID‐19	2020-05-11		.txt	text/plain	4017	213	48	Neuraminidase inhibitors such as oseltamivir, peramivir, and zanamivir are invalid for 2019‐nCoV and are not recommended for treatment but protease inhibitors such as lopinavir/ritonavir (LPV/r) inhibit the progression of MERS‐CoV disease and can be useful for patients of COVID‐19 and, in combination with Arbidol, has a direct antiviral effect on early replication of SARS‐CoV. Chloroquine inhibits SARS-CoV entry, which exerts its inhibitory effect by altering glycosylation of the ACE2 receptor and spike protein. | 5 in a MERS-CoV rhesus macaque model were promising, with the results of the trial and the effect of ribavirin and IFN (either α2a or β1) on MERS-CoV infected patients it was different, however, ribavirin lowers hemoglobin concentrations in respiratory patients and therefore reduces its potential as an antiviral against SARS-CoV-2 (Arabi et al., 2017; Falzarano et al., 2013) .	./cache/cord-352256-qxdakdk0.txt	./txt/cord-352256-qxdakdk0.txt